Anti-programmed cell death protein 1 (PD1) mAbs have become pivotal in cancer immunotherapy and are currently among the top-selling drugs. (1−3) Developing novel and biosimilar anti-PD1 mAbs is ...

The delicate balance between cell death and regeneration is crucial for human health and longevity. Most mechanisms involved ...

Teva Pharmaceutical has announced a collaboration with Shanghai Fosun Pharmaceutical (Fosun Pharma) to advance the global development of the anti-programmed cell death protein 1 (PD1)-Interleukin-2 ...

Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers ...

The authors noted that there are currently 3 immune-oncologic antibody treatments approved for locally advanced and metastatic cSCCs that target the programmed cell death protein 1/programmed ...

Cancer plasticity allows tumor cells to change their identity, evade therapies, and adapt to environmental pressures, contributing to treatment resistance and metastasis. New research is targeting ...

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Researchers at the University of Cologne have identified the key mitochondrial protein AIFM1 as a central coordinator of ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...

Glenmark Pharma launches Tevimbra in India to treat lung and esophageal cancer: Our Bureau, Mumbai Tuesday, June 24, 2025, 14:15 Hrs [IST] Glenmark Pharmaceuticals Ltd, a research ...